National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine

Natalia Pelet Del Toro, Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.
Rayan Yahia, University of California, Riverside School of Medicine, California.
Steven R. Feldman, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Abby Van Voorhees, Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia.
Lawrence Green, Department of Dermatology, George Washington University School of Medicine, Washington, DC.
Sergio Schwartzman, Department of Rheumatology, Weill Cornell Medical Center, New York, New York.
Evan Siegel, Arthritis and Rheumatism Associates, Rockville, Maryland.
Kelly M. Cordoro, Department of Dermatology, University of California San Francisco, San Francisco, California.
Seemal R. Desai, Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
Leon Kircik, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
Wilson Liao, Department of Dermatology, University of California San Francisco, San Francisco, California.
Jason E. Hawkes, Department of Dermatology, University of California Davis Medical Center, University of California Davis Health System, Sacramento, California.
Jeffrey Weinberg, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
John Koo, Department of Dermatology, University of California San Francisco, San Francisco, California.
Elizabeth Brezinski Wallace, Department of Dermatology, University of Colorado, Aurora, Colorado.
Leah M. Howard, National Psoriasis Foundation, Portland, Oregon.
April Armstrong, Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California.
George Han, Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.

Document Type

Journal Article

Publication Date

9-1-2023

Journal

JAAD international

Volume

12

DOI

10.1016/j.jdin.2023.02.018

Keywords

biologics; psoriasis; psoriatic arthritis; teledermatology; telemedicine; topical therapy

Abstract

Telemedicine emerged as an alternative care delivery system used to offer effective long-term management to patients with chronic, inflammatory conditions such as psoriatic disease. Teledermatology can provide reliable clinical information through thorough history-taking and virtual evaluations that include patient-provided images and disease activity assessment tools that may help accurately diagnose and manage patients with psoriasis. The integration of validated screening tools for psoriatic arthritis and effective teledermatology practices may improve access to specialists, thus avoiding preventable delays in the diagnosis and treatment of patients with psoriatic arthritis. Although the provision of telehealthcare should not completely replace high quality, in-person dermatologic or rheumatologic visits, the convenience and collaborative nature of teledermatology may lead to expanded access and expedited care in the appropriate setting, whether it be in a virtual or in-person visit.

Department

Dermatology

Link to Full Text

Share

COinS